MTOR and ovarian cancer: Other reports associate the dual inhibition of PI3K/mTOR with a strong impact on suppression of cell proliferation, induction of cell cycle arrest and apoptosis in ovarian cancer cells, and the sensitizing for treatments with paclitaxel or cisplatin [50].